|
|
Cambridge Major Laboratories; Growing API Development and Manufacturing Business
Speaker: Brian Scanlan, Chief Business Officer
Brian’s creativity in positioning the company has bolstered CML's name and image as a top-tier supplier of advanced chemistry services. He has overseen the business aspects of CML for the past 7 years, during which time the company has undergone average growth of greater than 30% per year. Brian is responsible for developing and implementing global business strategy, including sales and marketing, planning/forecasting, contracts/legal issues, and project management. He brings significant industry experience in creating deals tailored to the clients specific needs and has been involved in several pharmaceutical contract chemistry organizations over the past 15 years ranging from startups to large Contract Manufactuing Organizations.
Prior to joining CML, Brian managed business development activities in North America for Rhodia ChiRex focusing on the emerging pharma and biotech sectors. Prior to Rhodia ChiRex, he helped form the startup company, Universal Pharma Technologies, where he was responsible for all technical sales and marketing efforts. The company was later acquired by Johnson Matthey. Brian started his career with petrochemical giant UOP where he was a R&D chemist, then later moved into the specialty chemicals group in various marketing roles. He received his MBA from the Stuart School of Business, Illinois Institute of Technology, and a BS in Chemistry from Northern Illinois University. Brian currently serves on the Board of Directors of the Wisconsin Biotechnology and Medical Device Association, and is active in several industry organizations.
Cambridge Major is the fastest growing chemistry-based Contract Research and Manufacturing Organization in the Western Hemisphere averaging over 30% annual growth rate since its inception in 1999. With four facilities in the US and Europe, the company offers process development, scale up, and GMP manufacture of clinical and commercial API’s. Currently, the company is completing a large scale manufacturing facility which is capable of producing multi-ton quantities of API. Cambridge Major has the most balanced portfolio of chemistry development/manufacturing services with the right mix of personnel, FDA-inspected facilities, and equipment to serve all of your chemistry needs from grams to multi-ton scale.
Contact Details:
Brian W. Scanlan
Chief Business Officer
Cambridge Major Laboratories, Inc.
ph: 262-251-5044 x-204
b.scanlan@c-mlabs.com
www.c-mlabs.com